Müller Günter, Wied Susanne, Straub Julia, Jung Christian
Sanofi-Aventis Pharma, Frankfurt am Main, Germany.
Eur J Pharmacol. 2008 Nov 12;597(1-3):6-18. doi: 10.1016/j.ejphar.2008.08.034. Epub 2008 Sep 3.
Inhibition of lipolysis by palmitate, H2O2 and the anti-diabetic sulfonylurea drug, glimepiride, in isolated rat adipocytes has previously been shown to rely on the degradation of cyclic adenosine monophosphate by the phosphodiesterase, Gce1, and the 5'-nucleotidase, CD73. These glycosylphosphatidylinositol (GPI)-anchored proteins are translocated from plasma membrane lipid rafts to intracellular lipid droplets upon H2O2-induced activation of a GPI-specific phospholipase C (GPI-PLC) in response to palmitate and glimepiride in intact adipocytes and, as demonstrated here, in cell-free systems as well. The same agents are also known to stimulate the incorporation of fatty acids into triacylglycerol. Here the involvement of H2O2 production, GPI-PLC activation and translocation of Gce1 and CD73 in the agent-induced esterification and accompanying lipid droplet formation was tested in rat adipocytes using relevant inhibitors. The results demonstrate that upregulation of the esterification and accumulation of triacylglycerol by glimepiride depends on the sequential H2O2-induced GPI-PLC activation and GPI-protein translocation as does inhibition of lipolysis. In contrast, stimulation of the esterification and triacylglycerol accumulation by palmitate relies on insulin-independent tyrosine phosphorylation and thus differs from its anti-lipolytic mechanism. As expected, insulin regulates lipid metabolism via typical insulin signalling independent of H2O2 production, GPI-PLC activation and GPI-protein translocation, albeit these processes are moderately stimulated by insulin. In conclusion, triacylglycerol and lipid droplet formation in response to glimepiride and H2O2 may involve the hydrolysis of cyclic adenosine monophosphate by lipid droplet-associated Gce1 and CD73 which may regulate lipid droplet-associated triacylglycerol-synthesizing and hydrolyzing enzymes in coordinated and inverse fashion.
先前的研究表明,在分离的大鼠脂肪细胞中,棕榈酸、过氧化氢和抗糖尿病磺脲类药物格列美脲对脂解的抑制作用依赖于磷酸二酯酶Gce1和5'-核苷酸酶CD73对环磷酸腺苷的降解。在完整的脂肪细胞中,响应棕榈酸和格列美脲,这些糖基磷脂酰肌醇(GPI)锚定蛋白在过氧化氢诱导的GPI特异性磷脂酶C(GPI-PLC)激活后,从质膜脂筏转移至细胞内脂滴,本文还证明,在无细胞系统中也是如此。同样已知这些物质会刺激脂肪酸掺入三酰甘油。在此,使用相关抑制剂在大鼠脂肪细胞中测试了过氧化氢生成、GPI-PLC激活以及Gce1和CD73的转位在这些物质诱导的酯化及伴随的脂滴形成中的作用。结果表明,格列美脲对三酰甘油酯化和积累的上调作用取决于过氧化氢诱导的GPI-PLC激活和GPI蛋白转位的顺序,脂解抑制也是如此。相反,棕榈酸对酯化和三酰甘油积累的刺激作用依赖于胰岛素非依赖性酪氨酸磷酸化,因此与其抗脂解机制不同。正如预期的那样,胰岛素通过典型的胰岛素信号通路调节脂质代谢,独立于过氧化氢生成、GPI-PLC激活和GPI蛋白转位,尽管这些过程会受到胰岛素的适度刺激。总之,对格列美脲和过氧化氢的反应中,三酰甘油和脂滴的形成可能涉及脂滴相关的Gce1和CD73对环磷酸腺苷的水解,这可能以协调和相反的方式调节脂滴相关的三酰甘油合成和水解酶。